BAIJIN LIFE SCI (01466) has collectively issued 67,925,200 share purchase rights.
Baiken Life Sciences (01466) announced that according to its stock option plan adopted on September 30, 2024, the company granted a total of 67,925,200 stock options to eligible participants on April 24, 2026, to subscribe for ordinary shares of the company at HK$0.02 per share. The stock options can only be exercised after acceptance by the grantee.
BAIJIN LIFE SCI (01466) announced that, according to its stock option plan adopted on September 30, 2024, the company granted a total of 67,925,200 stock options to eligible participants on April 24, 2026, to subscribe for ordinary shares of the company at a price of HK$0.02 per share. The stock options can only be exercised after they are accepted by the grantee.
Related Articles
ZERO2IPO (01945) spent HK$391,000 to repurchase 222,400 shares on April 24th.
XINTE ENERGY (01799) achieved a first quarter net profit attributable to shareholders of RMB 228 million.
.png)
BEIJING ENT (00392): Beijing Yanjing Brewery's net profit attributable to shareholders in the first quarter was 2.65 billion yuan, a year-on-year increase of 60.19%.
ZERO2IPO (01945) spent HK$391,000 to repurchase 222,400 shares on April 24th.
XINTE ENERGY (01799) achieved a first quarter net profit attributable to shareholders of RMB 228 million.
BEIJING ENT (00392): Beijing Yanjing Brewery's net profit attributable to shareholders in the first quarter was 2.65 billion yuan, a year-on-year increase of 60.19%.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
